These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29374968)

  • 1. Fibrinolytic Deficit and Platelet Activation in Atrial Fibrillation and Their Postablation Modulation.
    Otto A; Fareed J; Liles J; Statz S; Walborn A; Rowe T; Jabati S; Hoppensteadt D; Syed MA
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):803-807. PubMed ID: 29374968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly.
    Berge T; Ulimoen SR; Enger S; Arnesen H; Seljeflot I; Tveit A
    Scand J Clin Lab Invest; 2013; 73(4):326-33. PubMed ID: 23586783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
    Lim HS; Willoughby SR; Schultz C; Chakrabarty A; Alasady M; Lau DH; Roberts-Thomson KC; Worthley MI; Young GD; Sanders P
    Heart Rhythm; 2014 Nov; 11(11):1912-8. PubMed ID: 25068571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of Inflammation, Thrombogenesis, and Collagen Turnover in Patients With Atrial Fibrillation.
    Jabati S; Fareed J; Liles J; Otto A; Hoppensteadt D; Bontekoe J; Phan T; Walborn A; Syed M
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):718-723. PubMed ID: 29558818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of immature platelet fraction and inflammatory markers in atrial fibrillation patients - Does persistency or ablation affect results?
    Perelshtein Brezinov O; Sevylia Z; Rahkovich M; Kakzanov Y; Yahud E; Fortis L; Kogan Y; Asher E; Lev E; Laish-Farkash A
    Int J Lab Hematol; 2021 Aug; 43(4):602-608. PubMed ID: 33289968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of Soluble Thrombomodulin and Circulating miRNAs in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation.
    Namino F; Yamakuchi M; Iriki Y; Okui H; Ichiki H; Maenosono R; Oketani N; Masamoto I; Miyata M; Horiuchi M; Hashiguchi T; Ohishi M; Maruyama I
    Clin Appl Thromb Hemost; 2019; 25():1076029619851570. PubMed ID: 31140290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
    Bertaglia E; Bonso A; Zoppo F; Proclemer A; Verlato R; Corò L; Mantovan R; Themistoclakis S; Raviele A; Pascotto P;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1507-12. PubMed ID: 15546305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
    Lim HS; Willoughby SR; Schultz C; Gan C; Alasady M; Lau DH; Leong DP; Brooks AG; Young GD; Kistler PM; Kalman JM; Worthley MI; Sanders P
    J Am Coll Cardiol; 2013 Feb; 61(8):852-60. PubMed ID: 23333141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A
    Europace; 2015 Dec; 17(12):1807-15. PubMed ID: 25995388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.
    Bulava A; Slavík L; Fiala M; Heinc P; Skvarilova M; Lukl J; Krcová V; Indrák K
    J Interv Card Electrophysiol; 2004 Jun; 10(3):271-9. PubMed ID: 15133367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical atrial flutter ablation and the risk of postablation atrial fibrillation.
    Bertaglia E; Shah D
    Ital Heart J; 2005 Dec; 6(12):946-9. PubMed ID: 16502707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence.
    Kızılırmak F; Gokdeniz T; Gunes HM; Demir GG; Cakal B; Guler GB; Guler E; Olgun FE; Kilicaslan F
    Kardiol Pol; 2017; 75(2):126-134. PubMed ID: 27221959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
    Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
    Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors.
    Gibson DN; Di Biase L; Mohanty P; Patel JD; Bai R; Sanchez J; Burkhardt JD; Heywood JT; Johnson AD; Rubenson DS; Horton R; Gallinghouse GJ; Beheiry S; Curtis GP; Cohen DN; Lee MY; Smith MR; Gopinath D; Lewis WR; Natale A
    Heart Rhythm; 2011 Sep; 8(9):1364-71. PubMed ID: 21354332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
    Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of thrombogenic, endothelial and inflammatory markers in supraventricular tachycardia: a study in patients with structurally normal hearts.
    Schultz CD; Rangneker G; Lim HS; Fraudeau A; Young G; Roberts-Thomson K; John B; Worthley M; Sanders P; Willoughby SR
    Clin Exp Pharmacol Physiol; 2014 Aug; 41(8):551-7. PubMed ID: 24827644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofibrinolysis in atrial fibrillation.
    Roldán V; Marín F; Marco P; Martínez JG; Calatayud R; Sogorb F
    Am Heart J; 1998 Dec; 136(6):956-60. PubMed ID: 9842006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.